Featured Announcements
November 22, 2021
UAMS Researchers Receive $1.5 Million to Study Impact of Maternal Diabetes on Fetal Neurodevelopment

LITTLE ROCK —Researchers at the University of Arkansas for Medical Sciences (UAMS) hope to gain important insights about fetal neurodevelopment in a new study with diabetic pregnant mothers. Funded by a four-year, $1.5 million grant from the National Institutes of Health (NIH), the first study of its kind will use advanced fetal monitoring techniques and…
November 18, 2021
UAMS College of Nursing Ranks 43rd in Nation in U.S. News & World Report’s List of Best BSN Programs

U.S. News and World Report ranked the College of Nursing at the University of Arkansas for Medical Sciences (UAMS) among the top 50 undergraduate nursing programs for 2022.
November 15, 2021
UAMS Receives $18.9 Million NIH Award to Address Health Disparities

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…
November 8, 2021
UAMS, Arkansas Children’s to Offer Pediatric COVID Vaccines

Beginning Nov. 9, the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s will offer pediatric COVID-19 vaccines for children ages 5 to 11 at the UAMS Vaccine Clinic at 401 S. Monroe St. in Little Rock.
November 4, 2021
UAMS Receives Full Accreditation, Area of Distinction for its Human Research Protection Program

The University of Arkansas for Medical Sciences (UAMS) Human Research Protection Program was fully accredited recently for another five years by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). UAMS became one of the first 25 institutions in the United States to receive the accreditation in 2005 and has maintained it since…
November 1, 2021
NIH Awards $13.8 Million to Test UAMS-Discovered Drug for Methamphetamine Use Disorder Treatment

A drug discovered at the University of Arkansas for Medical Sciences (UAMS) to counter the effects of methamphetamine will be tested in a phase 2 clinical trial as the only potential treatment of its kind for methamphetamine use disorder.
October 28, 2021
UAMS Researchers See 12% Increase in Grant Funding for FY2021

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…
October 26, 2021
NCI Grant Supporting UAMS Research to Improve Cancer Treatment for Patients Lacking Good Gut Bacteria

LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team will use a National Cancer Institute (NCI) grant to study promising new ways to improve the effectiveness of a common cancer treatment for patients lacking beneficial gut bacteria. The five-year, nearly $2 million grant is led by Ruud P.M. Dings, Ph.D., M.Sc., an…
October 19, 2021
UAMS Named Top 10% in Nation for Joint Replacement

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) ranks among the top 10% in the nation for joint replacement surgery for the second year in a row, according to Healthgrades, the leading resource that connects consumers, physicians and health systems.
October 14, 2021
UAMS Celebrates Completion of New, $50 Million Electrical Power Plant at Little Rock Campus

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) today celebrated the completion of a new $50 million electrical power plant on the east side of its Little Rock campus.
Next page